Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 8, Pages 18865-18877
Publisher
MDPI AG
Online
2015-08-12
DOI
10.3390/ijms160818865
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update
- (2015) Juan Segura-Aguilar et al. NEUROTOXICITY RESEARCH
- Hematopoietic cytokines as therapeutic players in early stages Parkinson’s disease
- (2015) Kyle Farmer et al. Frontiers in Aging Neuroscience
- Sphingolipids: Key Regulators of Apoptosis and Pivotal Players in Cancer Drug Resistance
- (2014) Paola Giussani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson’s disease: respirometric, histological, and behavioral analyses
- (2014) Andreas Kupsch et al. JOURNAL OF NEURAL TRANSMISSION
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Involvement of activation of the Nrf2/ARE pathway in protection against 6-OHDA-induced SH-SY5Y cell death by α-iso-cubebenol
- (2014) Sun Young Park et al. NEUROTOXICOLOGY
- Protein Kinase D1 (PKD1) Phosphorylation Promotes Dopaminergic Neuronal Survival during 6-OHDA-Induced Oxidative Stress
- (2014) Arunkumar Asaithambi et al. PLoS One
- Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease
- (2013) Simon R.W. Stott et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Neuroprotective effects of swimming training in a mouse model of Parkinson’s disease induced by 6-hydroxydopamine
- (2013) A.T.R. Goes et al. NEUROSCIENCE
- PGE2 EP1 Receptor Deletion Attenuates 6-OHDA-Induced Parkinsonism in Mice: Old Switch, New Target
- (2013) Abdullah Shafique Ahmad et al. NEUROTOXICITY RESEARCH
- NADPH Oxidase and the Degeneration of Dopaminergic Neurons in Parkinsonian Mice
- (2013) Marina S. Hernandes et al. Oxidative Medicine and Cellular Longevity
- Microglial Cells Are Involved in the Susceptibility of NADPH Oxidase Knockout Mice to 6-Hydroxy-Dopamine-Induced Neurodegeneration
- (2013) Marina S. Hernandes et al. PLoS One
- Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
- (2013) Michelle M. Mielke et al. PLoS One
- Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation
- (2012) Isabel Gonçalves et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Functions of plasmalogen lipids in health and disease
- (2012) Nancy E. Braverman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Unknown
- (2011) Noemi Fabelo et al. MOLECULAR MEDICINE
- Vacuolar Import of Phosphatidylcholine Requires the ATP-Binding Cassette Transporter Ybt1
- (2011) Kailash Gulshan et al. TRAFFIC
- A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats
- (2011) Mohammed Emamussalehin Choudhury et al. Brain and Behavior
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
- (2010) Mohd.Moshahid Khan et al. BRAIN RESEARCH
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Effects of lysophosphatidylcholine on β-amyloid-induced neuronal apoptosis
- (2009) Zhen-xia Qin et al. ACTA PHARMACOLOGICA SINICA
- Mitochondrial dysfunction in Parkinson's disease
- (2009) Konstanze F. Winklhofer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- PPARδ is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction
- (2009) Kim Ravnskjaer et al. JOURNAL OF LIPID RESEARCH
- Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson’s disease
- (2009) Lilia Marinova-Mutafchieva et al. JOURNAL OF NEUROCHEMISTRY
- Brain Arachidonic Acid Cascade Enzymes are Upregulated in a Rat Model of Unilateral Parkinson Disease
- (2009) Ho-Joo Lee et al. NEUROCHEMICAL RESEARCH
- Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties
- (2008) Timothy J Cunningham et al. Journal of Inflammation-London
- The 6-hydroxydopamine model: News from the past
- (2008) Fabio Blandini et al. PARKINSONISM & RELATED DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now